How can we alleviate the burden of antibiotic resistance?

  27 October 2021

Antibiotic resistance is a growing public health concern, threatening the lives of millions of people around the world. Antimicrobial resistance (AMR) occurs when natural bacteria within the body are mutated so that they are no longer killed by antibiotics. Effective antibiotics are crucial, as nearly every medical procedure is dependent on them being effective. Currently, antibiotic resistance claims the lives of 700,000 people per year globally, this is predicted to increase to 10 million by 2050 if the current situation is not improved.

One person who seeks to improve this current situation is Professor Colin Garner, CEO of Antibiotic Research UK (ANTRUK). Through ANTRUK, Garner aims to see a world free from drug-resistant infections through increased research, education, and patient support. With the goal of bringing at least one new antibiotic treatment to market by the early 2020s, ANTRUK is currently raising funds and supporting world-class, peer-reviewed research. Here, Garner tells Health Europa about the necessary steps that ANTRUK is taking in order to raise awareness about AMR and discusses how policies can be implemented to reduce the number of associated deaths.

Further reading: Health Europe
Author(s): Colin Garner
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


JSS University


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!